VANCOUVER, British Columbia, March 28, 2005 (PRIMEZONE) -- Larrea Biosciences Corporation (OTCBB:LRRA) announced it will be amending and supplementing certain previously filed 8-Ks and restating its October 31, 2004 quarterly financial statements regarding the accounting treatment of certain the financial statement valuations related to the acquisitions of Global Botanics, Inc., the four patents on its proprietary Virastatin(tm) Larrea Tridentata extract process and the acquisition of LarreaRx, Inc.
